Pharma BD Deal Intelligence

DPx Holdings B.V. (JLL Partners 51% / Royal DSM 49%) / Patheon Inc. + DSM Pharmaceutical Products

2013 · Acquisition/Merger · $2.6B · Complete

JLL Partners and Royal DSM created DPx Holdings BV (later Patheon NV) by combining DSM Pharmaceutical Products and Patheon in $2.6B transaction; Patheon enterprise value ~$1.98B at $9.32/share.

Did it work? Outcome assessment

Assessment window: 5yr post-close.

Key facts

• Announced Nov 19, 2013
• Closed Mar 11, 2014
• Deal value $2.6B
• Deal type Acquisition/Merger
• Therapeutic area Contract manufacturing
• Indications Contract manufacturing
• Key assets Global CDMO services (oral solids, sterile fill, biologics)
• Mechanism Contract Development and Manufacturing

← Browse all deals  ·  How we score deals